Target
Ubiquitin carboxyl-terminal hydrolase 16
Ligand
BDBM50538571
Substrate
n/a
Meas. Tech.
ChEMBL_1973162 (CHEMBL4605980)
IC50
>10000±n/a nM
Citation
 Leger, PRHu, DXBiannic, BBui, MHan, XKarbarz, EMaung, JOkano, AOsipov, MShibuya, GMYoung, KHiggs, CAbraham, BBradford, DCho, CColas, CJacobson, SOhol, YMPookot, DRana, PSanchez, JShah, NSun, MWong, SBrockstedt, DGKassner, PDSchwarz, JBWustrow, DJ Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor Activity. J Med Chem 63:5398-5420 (2020) [PubMed]  Article 
Target
Name:
Ubiquitin carboxyl-terminal hydrolase 16
Synonyms:
3.4.19.12 | Deubiquitinating enzyme 16 | UBP16_HUMAN | USP16 | Ubiquitin carboxyl-terminal hydrolase 16 | Ubiquitin thioesterase 16 | Ubiquitin-processing protease UBP-M | Ubiquitin-specific-processing protease 16
Type:
PROTEIN
Mol. Mass.:
93575.20
Organism:
Homo sapiens
Description:
ChEMBL_119958
Residue:
823
Sequence:
MGKKRTKGKTVPIDDSSETLEPVCRHIRKGLEQGNLKKALVNVEWNICQDCKTDNKVKDKAEEETEEKPSVWLCLKCGHQGCGRNSQEQHALKHYLTPRSEPHCLVLSLDNWSVWCYVCDNEVQYCSSNQLGQVVDYVRKQASITTPKPAEKDNGNIELENKKLEKESKNEQEREKKENMAKENPPMNSPCQITVKGLSNLGNTCFFNAVMQNLSQTPVLRELLKEVKMSGTIVKIEPPDLALTEPLEINLEPPGPLTLAMSQFLNEMQETKKGVVTPKELFSQVCKKAVRFKGYQQQDSQELLRYLLDGMRAEEHQRVSKGILKAFGNSTEKLDEELKNKVKDYEKKKSMPSFVDRIFGGELTSMIMCDQCRTVSLVHESFLDLSLPVLDDQSGKKSVNDKNLKKTVEDEDQDSEEEKDNDSYIKERSDIPSGTSKHLQKKAKKQAKKQAKNQRRQQKIQGKVLHLNDICTIDHPEDSEYEAEMSLQGEVNIKSNHISQEGVMHKEYCVNQKDLNGQAKMIESVTDNQKSTEEVDMKNINMDNDLEVLTSSPTRNLNGAYLTEGSNGEVDISNGFKNLNLNAALHPDEINIEILNDSHTPGTKVYEVVNEDPETAFCTLANREVFNTDECSIQHCLYQFTRNEKLRDANKLLCEVCTRRQCNGPKANIKGERKHVYTNAKKQMLISLAPPVLTLHLKRFQQAGFNLRKVNKHIKFPEILDLAPFCTLKCKNVAEENTRVLYSLYGVVEHSGTMRSGHYTAYAKARTANSHLSNLVLHGDIPQDFEMESKGQWFHISDTHVQAVPTTKVLNSQAYLLFYERIL
  
Inhibitor
Name:
BDBM50538571
Synonyms:
CHEMBL4635160
Type:
Small organic molecule
Emp. Form.:
C28H30ClN3O3S
Mol. Mass.:
524.074
SMILES:
C[C@H]1CNCC[C@H]1Oc1c(C)cc(Cl)cc1-c1ccnc2cc(CN3C(=O)C4C(C3=O)C4(C)C)sc12 |r|
Structure:
Search PDB for entries with ligand similarity: